Portola Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer

Brings to Portola 20 Years of Clinical Development and Approval Experience SOUTH SAN FRANCISCO, Calif., Feb. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced the appointment of Rajiv... Biopharmaceuticals, Personnel Portola Pharmaceuticals, Andexxa, coagulation factor Xa, Bevyxxa, betrixaban
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news